External broker reports(aggregated public sources), CMB International

CMB International

External broker reports(aggregated public sources)

Incorporated in Hong Kong, supported by the mainland and targeting in global market, CMB International Capital Corporation Limited (“CMBI”) is an integrated financial institution providing comprehensive and professional services. As a wholly-owned subsidiary of China Merchants Bank ("CMB"), by leveraging on the Group’s synergy and coordination in domestic and overseas markets, as well as CMB’s strong resources and outstanding social reputation, CMBI and its subsidiaries have been actively implementing diversified business strategies and set up an overall layout of main business segments including Corporate Finance, Asset Management, Wealth Management, Global Markets and Structured Finance, etc. Adhering to the philosophy of “being clients oriented and increasing our own values by the way of creating value for clients”, CMBI endeavors to provide quality and integrated financial services to institutional, corporate and individual customers both domestic and overseas including Hong Kong IPO sponsorship and underwriting, share placement and rights issue for listed companies, financial advisors, bonds issuance services, asset management, direct investment, wealth management, equity sales and trading, etc.

Equity Bottom-Up

<ul><li>We recently spoke with TK Group (TK)’s mgmt. post FY23 earnings, and mgmt. reiterated positive view on order restocking, new client wins, capacity ramp-up in Vietnam/Huizhou and business opportunities in automotive/ medical device/ecigarette.</li><li>Following a challenging 2023, we expect TK’s net profit to grow 38%/19% YoY in FY24/25E, backed by order wins from VR/e-cigarette/medical device, mobile &amp; wearable/communications business recovery, and continued operating efficiency improvement.</li><li>We adjusted TP to HK$2.79 based on same 8.2x FY24E P/E. Trading at 4.4x FY24E P/E with 10% yield, we think the stock offers attractive risk/reward. Maintain BUY.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

We recently spoke with TK Group (TK)’s mgmt. post FY23 earnings, and mgmt. reiterated positive view on order restocking, new client wins, capacity ramp-up in Vietnam/Huizhou and business opportunities in automotive/ medical device/ecigarette.Following a challenging 2023, we expect TK’s net profit to grow 38%/19% YoY in FY24/25E, backed by order wins from VR/e-cigarette/medical device, mobile &amp; wearable/communications business recovery, and continued operating efficiency improvement.We adjusted TP to HK$2.79 based on same 8.2x FY24E P/E. Trading at 4.4x FY24E P/E with 10% yield, we think the stock offers attractive risk/reward. Maintain BUY.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

TK Group (2283 HK) - Positive on Business Recovery in FY24/25E

<ul><li>TK posted 1H23 revenue/NP decline of 12%/6% YoY, mainly due to demand weakness across segments (except automotive), partly offset by improved GPM to 23.3% (vs. 18.7% in 1H22) on easing cost pressure and enhanced efficiency.</li><li>Looking ahead, mgmt. is positive on new client orders, capacity ramp-up in Shenzhen/Vietnam/Huizhou plants and business opportunities in automotive/ medical device/e-cigarette.</li><li>Following a weak 2023, we expect net profit to grow 33%/16% YoY in FY24/25E, backed by order wins from VR/e-cigarette/medical device, GPM recovery and better cost control. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

TK posted 1H23 revenue/NP decline of 12%/6% YoY, mainly due to demand weakness across segments (except automotive), partly offset by improved GPM to 23.3% (vs. 18.7% in 1H22) on easing cost pressure and enhanced efficiency.Looking ahead, mgmt. is positive on new client orders, capacity ramp-up in Shenzhen/Vietnam/Huizhou plants and business opportunities in automotive/ medical device/e-cigarette.Following a weak 2023, we expect net profit to grow 33%/16% YoY in FY24/25E, backed by order wins from VR/e-cigarette/medical device, GPM recovery and better cost control. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

TK Group (2283 HK) – 1H23 Weakness Amid Industry Headwinds

<ul>
<li>Apple is widely expected to launch its long-awaited MR headset in WWDC 2023 this week.</li>
<li>We believe 2023 is set to be one of the best years in VR/AR ecosystem development as Apple’s first MR headset will set new standard for innovation.</li>
<li>We expect technology upgrade to accelerate in displays, optics/sensors and tracking/interaction for enhancing user experience. </li>
</ul>
Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.


Apple is widely expected to launch its long-awaited MR headset in WWDC 2023 this week.
We believe 2023 is set to be one of the best years in VR/AR ecosystem development as Apple’s first MR headset will set new standard for innovation.
We expect technology upgrade to accelerate in displays, optics/sensors and tracking/interaction for enhancing user experience. 

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

China Technology – Apple MR: Long-awaited next “iPhone moment”

Independent Research, Turtles all the way down

Turtles all the way down

Independent Research

Writing short articles about mis-priced boring stocks around the world.

<ul><li>I mentioned Noah holdings as a trade to buy before earnings since I anticipated an announcement of significant capital returns.</li><li>This has worked out well with over $2 in dividends announced. Half of that dividend will be recurring.</li><li>So I sold out all of my shares at just under $12. This was never a high conviction investment, but merely a trade. Marking it as a 18% return.</li></ul>

I mentioned Noah holdings as a trade to buy before earnings since I anticipated an announcement of significant capital returns.This has worked out well with over $2 in dividends announced. Half of that dividend will be recurring.So I sold out all of my shares at just under $12. This was never a high conviction investment, but merely a trade. Marking it as a 18% return.

<ul><li>Recently Avrobio (AVRO) announced a reverse merger with Tectonic Therapeutic, which was a bit unexpected.</li><li>And disappointing. From what I have read from people more knowledgeable about biotechs, they have some promising treatments in development with pretty impressive insiders.</li><li>But I have no idea how to value this. Net cash will be &lt;$1/share post merger so I am closing this with a small loss at $1.25.</li></ul>

Recently Avrobio (AVRO) announced a reverse merger with Tectonic Therapeutic, which was a bit unexpected.And disappointing. From what I have read from people more knowledgeable about biotechs, they have some promising treatments in development with pretty impressive insiders.But I have no idea how to value this. Net cash will be &lt;$1/share post merger so I am closing this with a small loss at $1.25.

Hong Kong

TK Group (Holdings) Limited manufactures plastic products and components. The Company engages in the design and fabrication of plastic injection molds and the mechanical design and manufacturing of plastic components.

TK Group (Holdings) (2283 HK)

TK Group (2283 HK) - Positive on Business Recovery in FY24/25E

We adjusted TP to HK$2.79 based on same 8.2x FY24E P/E. Trading at 4.4x FY24E P/E with 10% yield, we think the stock offers attractive risk/reward....

CMB International

TK Group (2283 HK) – 1H23 Weakness Amid Industry Headwinds

TK posted 1H23 revenue/NP decline of 12%/6% YoY, mainly due to demand weakness across segments (except automotive), partly offset by improved GPM...

CMB International

China Technology – Apple MR: Long-awaited next “iPhone moment”

We believe 2023 is set to be one of the best years in VR/AR ecosystem development as Apple’s first MR headset will set new standard for innovation.

CMB International

Update on active Ideas

I mentioned Noah holdings as a trade to buy before earnings since I anticipated an announcement of significant capital returns.

Turtles all the way down

Some updates

From what I have read from people more knowledgeable about biotechs, they have some promising treatments in development with pretty impressive...

Turtles all the way down